Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Instituto do Câncer Brasil (ICB) is a specialized healthcare provider focused on comprehensive oncology care across several regions in Brazil. The institute offers a wide range of services including chemotherapy, immunotherapy, hormone therapy, and targeted treatments, alongside multidisciplinary support in nutrition, psychology, and pharmacy. ICB operates as a network of clinics designed to provide humanized and high-quality cancer treatment, utilizing advanced medical protocols and clinical research to improve patient outcomes. The organization serves as a critical hub for cancer management, integrating diagnostic support and therapeutic interventions for various solid tumors and hematological conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Instituto do Câncer Brasil.